세계의 생동일성 호르몬 시장 보고서(2025년)

Bioidentical Hormones Global Market Report 2025

US $ 4,490 ￦ 6,339,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,163,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,987,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

생동일성 호르몬 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 연평균 6.3%의 성장률로 102억 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 여성 건강에 대한 관심 증가, 개인 맞춤형 의료에 대한 수용 확대, 정부 지원 정책, 만성 질환의 유병률 증가, 생동일성 호르몬의 이점에 대한 인식 증가에 기인합니다. 예측 기간 동안 주요 동향으로는 새로운 생동일성 호르몬 제제의 개발, 호르몬 치료 상담을 위한 원격 의료의 활용 증가, 주류 의료에서 생동일성 호르몬의 통합 증가, 호르몬 전달 시스템의 발전, 호르몬 생산에서 바이오 테크놀로지의 역할 확대 등을 들 수 있습니다. 확대 등을 들 수 있습니다.

개인 맞춤형 의료에 대한 수요 증가는 생동일성 호르몬 시장의 성장을 가속할 것으로 예측됩니다. 개인 맞춤형 의료는 유전학, 생활습관 등 개인의 특성에 따라 치료를 맞춤화하여 효능을 높이고 부작용을 감소시키는 것입니다. 이러한 수요 증가는 보다 효과적인 치료법 제공 가능성, 유전체학의 발전, 질병의 복잡성 증가, 규제 당국의 지원 등에 기인합니다. 생동일성 호르몬은 환자 고유의 호르몬 프로파일에 맞추어 치료 효과를 높이고 부작용을 최소화하여 개인 맞춤형 의료를 실현할 수 있습니다. 예를 들어, 2024년 2월 개인맞춤의료연합(Personalized Medicine Coalition)은 FDA가 2023년에 희귀질환을 위한 16개의 새로운 개인맞춤형 치료제를 승인했으며, 이는 2022년의 6개에서 증가한 것이라고 보고했습니다. 이처럼 개인맞춤형 의료에 대한 수요 증가는 생동일성 호르몬 시장에 박차를 가하고 있습니다.

생동일성 호르몬 시장의 주요 기업들은 호르몬 불균형 및 관련 건강 상태에 대한 보다 효과적이고 개인화된 치료를 제공하기 위해 생물학적 동일성 호르몬 대체 요법(BHRT)과 같은 첨단 솔루션 개발에 주력하고 있습니다. 호르몬과 화학적으로 동일한 호르몬을 사용하여 호르몬 불균형 및 관련 증상에 대처합니다. 예를 들어, 2024년 5월 인도 제약사 Jagson Pearl Pharmaceuticals Limited는 미국 FDA 승인을 받은 생물학적 동등성 호르몬 치료제인 멤업 HRT를 출시했습니다. 이 치료제는 생물학적 동질성 에스트라디올과 프로게스테론을 결합한 한 알의 알약 솔루션이 특징이며, 9개 지역 언어로 지원받을 수 있습니다. 이번 출시는 생동일성 호르몬을 활용한 균형 잡힌 호르몬 보충을 통해 환자의 순응도를 높이고, 갱년기 관리에 대한 인식을 높이고, 환자 결과를 개선하며, 인도 여성들의 건강 관리 옵션을 확대하는 것을 목표로 하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 신형 코로나바이러스, 그리고 경기회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 생동일성 호르몬 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
• 최종 이용 산업 분석
• 세계의 생동일성 호르몬 시장 : 성장률 분석
• 세계의 생동일성 호르몬 시장 실적 : 규모와 성장, 2019-2024
• 세계의 생동일성 호르몬 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 생동일성 호르몬 전체 시장(TAM)

제6장 시장 세분화

• 세계의 생동일성 호르몬 시장 : 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 에스트로겐
• 프로게스테론
• 테스토스테론
• 기타 유형
• 세계의 생동일성 호르몬 시장 : 제품 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 정제 및 캡슐
• 크림 및 젤
• 패치 및 임플란트
• 주사제
• 기타 제품 유형
• 세계의 생동일성 호르몬 시장 : 유통 채널별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원 약국
• 소매 약국
• 온라인 약국
• 기타 유통 채널
• 세계의 생동일성 호르몬 시장 : 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 갱년기 관리
• 호르몬 대체요법(HRT)
• 갑상선 질환
• 남성 갱년기 장애 관리
• 세계의 생동일성 호르몬 시장 : 최종 용도별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 부인과 클리닉
• 연구실
• 기타 최종사용자
• 세계의 생동일성 호르몬 시장 : 에스트로겐 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Estrone (E1)
• Estradiol (E2)
• Estriol (E3)
• Bioidentical Estradiol Creams
• Bioidentical Estrone Creams
• 세계의 생동일성 호르몬 시장 프로게스테론 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Bioidentical Progesterone Creams
• Bioidentical Progesterone Capsules
• Bioidentical Progesterone Injections
• 세계의 생동일성 호르몬 시장 테스토스테론 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Bioidentical Testosterone Creams
• Bioidentical Testosterone Injections
• Bioidentical Testosterone Pellets
• Bioidentical Testosterone Gels
• 세계의 생동일성 호르몬 시장 : 기타 유형별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Dhea (Dehydroepiandrosterone)
• Thyroid Hormones (T3, T4)
• Cortisol
• Melatonin
• Human Growth Hormone (Hgh)

제7장 지역별/국가별 분석

• 세계의 생동일성 호르몬 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 생동일성 호르몬 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 생동일성 호르몬 시장 : 경쟁 구도
• 생동일성 호르몬 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Hikma Pharmaceuticals Plc
• TherapeuticsMD Inc.
• Gedeon Richter Plc
• Noven Pharmaceuticals Inc.
• AnazaoHealth Corp.
• Women's International Pharmacy Inc.
• Wells Pharmacy Network
• ZRT Laboratory LLC
• BionPharma Inc.
• Orion Pharma AB
• Actiza Pharmaceutical Private Limited
• Biostation
• Advantage Pharmaceuticals Inc.
• Bravado Labs
• Neuva Aesthetics

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 생동일성 호르몬 시장(2029년) : 새로운 기회를 제공하는 국가
• 생동일성 호르몬 시장(2029년) : 새로운 기회를 제공하는 부문
• 생동일성 호르몬 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Bioidentical hormones are identical in chemical structure to those naturally produced by the human body, often used in hormone replacement therapy to address imbalances. They are particularly effective in easing symptoms associated with menopause, andropause, and other hormonal deficiencies, such as hot flashes, night sweats, mood swings, and low libido.

The primary bioidentical hormones include estrogen, progesterone, testosterone, and others. Estrogen, a key female sex hormone, regulates reproductive and secondary sexual characteristics. These hormones are available in various forms such as tablets, capsules, creams, gels, patches, implants, and injectables. They are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and other channels. Applications for bioidentical hormones include managing menopause, hormone replacement therapy (HRT), thyroid disorders, and andropause. They are utilized by diverse end-users such as hospitals, gynecology clinics, research laboratories, and others.

The bioidentical hormones market research report is one of a series of new reports from The Business Research Company that provides bioidentical hormones market statistics, including bioidentical hormones industry global market size, regional shares, competitors with a bioidentical hormones market share, detailed bioidentical hormones market segments, market trends and opportunities, and any further data you may need to thrive in the bioidentical hormones industry. This bioidentical hormones market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bioidentical hormones market size has grown strongly in recent years. It will grow from $7.49 billion in 2024 to $7.99 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to a rise in awareness of hormone-related health issues, increased prevalence of hormonal imbalances, increased aging population, increased healthcare expenditure, and increased demand for alternative medicine.

The bioidentical hormones market size is expected to see strong growth in the next few years. It will grow to $10.2 billion in 2029 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing focus on women's health, growing acceptance of personalized medicine, supportive government policies, increasing prevalence of chronic diseases, and rising awareness of the benefits of bioidentical hormones. Major trends in the forecast period include the development of novel bioidentical hormone formulations, growing use of telemedicine for hormone therapy consultations, increasing integration of bioidentical hormones in mainstream medicine, advancements in hormone delivery systems, and the expanding role of biotechnology in hormone production.

The increasing demand for personalized medicine is anticipated to drive the growth of the bioidentical hormones market. Personalized medicine involves customizing medical treatment based on individual characteristics, such as genetics or lifestyle, to enhance effectiveness and reduce adverse effects. This growing demand stems from its potential to offer more effective treatments, advancements in genomics, increasing disease complexity, and regulatory support. Bioidentical hormones align with personalized medicine by matching a patient's specific hormonal profile, improving treatment efficacy, and minimizing side effects. For instance, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized therapies for rare diseases in 2023, up from six in 2022. Thus, the rising demand for personalized medicine is fueling the bioidentical hormones market.

Leading companies in the bioidentical hormones market are focusing on developing advanced solutions such as bioidentical hormone replacement therapy (BHRT) to provide more effective and personalized treatments for hormonal imbalances and related health conditions. BHRT uses hormones that are chemically identical to those produced by the human body to address hormone imbalances and associated symptoms. For example, in May 2024, Jagsonpal Pharmaceuticals Limited, an Indian pharmaceutical company, launched MemUp HRT, a US FDA-approved bioidentical hormone therapy. This therapy features a single-pill solution combining bioidentical estradiol and progesterone, with support available in nine regional languages. This launch aims to leverage bioidentical hormones for balanced hormone replacement and improve patient compliance, thereby raising awareness about menopause management, enhancing patient outcomes, and expanding healthcare options for women in India.

In January 2024, BioTE Medical, LLC, a US-based healthcare company, acquired Asteria Health for $8.5 million. This acquisition strengthens BioTE's supply chain, enhances manufacturing capabilities, and improves its margin profile, positioning BioTE as a vertically integrated leader in the bioidentical hormones market and ensuring reliable access to innovative therapeutic wellness solutions. Asteria Health, based in the UK, provides pharmaceutical compounding solutions, including compounded bioidentical hormones.

Major companies operating in the bioidentical hormones market are Pfizer Inc., AbbVie Inc., Bayer AG, Abbott Laboratories Inc., Merck KGaA, Hikma Pharmaceuticals Plc, TherapeuticsMD Inc., Gedeon Richter Plc, Noven Pharmaceuticals Inc., AnazaoHealth Corp., Women's International Pharmacy Inc., Wells Pharmacy Network, ZRT Laboratory LLC, BionPharma Inc., Orion Pharma AB, Actiza Pharmaceutical Private Limited, Biostation, Advantage Pharmaceuticals Inc., Bravado Labs, Neuva Aesthetics, Papillon Medical, United Pharmacy LLC, SottoPelle Inc., Apotheca Compounding Pharmacy, MedQuest Pharmacy

North America was the largest region in the bioidentical hormones market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioidentical hormones market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bioidentical hormones market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bioidentical hormones market includes revenues earned by entities by providing services such as personalized hormone level testing, compounding pharmacy services, anti-aging treatments, wellness and longevity programs, weight management support, and integrative health services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bioidentical Hormones Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bioidentical hormones market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bioidentical hormones ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioidentical hormones market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Estrogen; Progesterone; Testosterone; Other Types
• 2) By Product Type: Tablet And Capsule; Cream And Gel; Patch And Implant; Injectable; Other Product Types
• 3) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Other Distribution Channels
• 4) By Application: Menopause Management; Hormone Replacement Therapy (HRT); Thyroid Disorders; Andropause Management
• 5) By End-use: Hospitals; Gynecology Clinics; Research Laboratories; Other End-Users
• Subsegments:
• 1) By Estrogen: Estrone (E1); Estradiol (E2); Estriol (E3); Bioidentical Estradiol Creams; Bioidentical Estrone Creams
• 2) By Progesterone: Bioidentical Progesterone Creams; Bioidentical Progesterone Capsules; Bioidentical Progesterone Injections
• 3) By Testosterone: Bioidentical Testosterone Creams; Bioidentical Testosterone Injections; Bioidentical Testosterone Pellets; Bioidentical Testosterone Gels
• 4) By Other Types: Dhea (Dehydroepiandrosterone); Thyroid Hormones (T3, T4); Cortisol; Melatonin; Human Growth Hormone (Hgh)
• Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Bayer AG; Abbott Laboratories Inc.; Merck KGaA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bioidentical Hormones Market Characteristics

3. Bioidentical Hormones Market Trends And Strategies

4. Bioidentical Hormones Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Bioidentical Hormones Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bioidentical Hormones PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bioidentical Hormones Market Growth Rate Analysis
• 5.4. Global Bioidentical Hormones Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bioidentical Hormones Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bioidentical Hormones Total Addressable Market (TAM)

6. Bioidentical Hormones Market Segmentation

• 6.1. Global Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Estrogen
• Progesterone
• Testosterone
• Other Types
• 6.2. Global Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablet And Capsule
• Cream And Gel
• Patch And Implant
• Injectable
• Other Product Types
• 6.3. Global Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Other Distribution Channels
• 6.4. Global Bioidentical Hormones Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Menopause Management
• Hormone Replacement Therapy (HRT)
• Thyroid Disorders
• Andropause Management
• 6.5. Global Bioidentical Hormones Market, Segmentation By End-use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Gynecology Clinics
• Research Laboratories
• Other End-Users
• 6.6. Global Bioidentical Hormones Market, Sub-Segmentation Of Estrogen, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Estrone (E1)
• Estradiol (E2)
• Estriol (E3)
• Bioidentical Estradiol Creams
• Bioidentical Estrone Creams
• 6.7. Global Bioidentical Hormones Market, Sub-Segmentation Of Progesterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioidentical Progesterone Creams
• Bioidentical Progesterone Capsules
• Bioidentical Progesterone Injections
• 6.8. Global Bioidentical Hormones Market, Sub-Segmentation Of Testosterone, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Bioidentical Testosterone Creams
• Bioidentical Testosterone Injections
• Bioidentical Testosterone Pellets
• Bioidentical Testosterone Gels
• 6.9. Global Bioidentical Hormones Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dhea (Dehydroepiandrosterone)
• Thyroid Hormones (T3, T4)
• Cortisol
• Melatonin
• Human Growth Hormone (Hgh)

7. Bioidentical Hormones Market Regional And Country Analysis

• 7.1. Global Bioidentical Hormones Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bioidentical Hormones Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bioidentical Hormones Market

• 8.1. Asia-Pacific Bioidentical Hormones Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bioidentical Hormones Market

• 9.1. China Bioidentical Hormones Market Overview
• 9.2. China Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bioidentical Hormones Market

• 10.1. India Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bioidentical Hormones Market

• 11.1. Japan Bioidentical Hormones Market Overview
• 11.2. Japan Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bioidentical Hormones Market

• 12.1. Australia Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bioidentical Hormones Market

• 13.1. Indonesia Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bioidentical Hormones Market

• 14.1. South Korea Bioidentical Hormones Market Overview
• 14.2. South Korea Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bioidentical Hormones Market

• 15.1. Western Europe Bioidentical Hormones Market Overview
• 15.2. Western Europe Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bioidentical Hormones Market

• 16.1. UK Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bioidentical Hormones Market

• 17.1. Germany Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bioidentical Hormones Market

• 18.1. France Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bioidentical Hormones Market

• 19.1. Italy Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bioidentical Hormones Market

• 20.1. Spain Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bioidentical Hormones Market

• 21.1. Eastern Europe Bioidentical Hormones Market Overview
• 21.2. Eastern Europe Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bioidentical Hormones Market

• 22.1. Russia Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bioidentical Hormones Market

• 23.1. North America Bioidentical Hormones Market Overview
• 23.2. North America Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bioidentical Hormones Market

• 24.1. USA Bioidentical Hormones Market Overview
• 24.2. USA Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bioidentical Hormones Market

• 25.1. Canada Bioidentical Hormones Market Overview
• 25.2. Canada Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bioidentical Hormones Market

• 26.1. South America Bioidentical Hormones Market Overview
• 26.2. South America Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bioidentical Hormones Market

• 27.1. Brazil Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bioidentical Hormones Market

• 28.1. Middle East Bioidentical Hormones Market Overview
• 28.2. Middle East Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bioidentical Hormones Market

• 29.1. Africa Bioidentical Hormones Market Overview
• 29.2. Africa Bioidentical Hormones Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bioidentical Hormones Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bioidentical Hormones Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bioidentical Hormones Market Competitive Landscape And Company Profiles

• 30.1. Bioidentical Hormones Market Competitive Landscape
• 30.2. Bioidentical Hormones Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

31. Bioidentical Hormones Market Other Major And Innovative Companies

• 31.1. Hikma Pharmaceuticals Plc
• 31.2. TherapeuticsMD Inc.
• 31.3. Gedeon Richter Plc
• 31.4. Noven Pharmaceuticals Inc.
• 31.5. AnazaoHealth Corp.
• 31.6. Women's International Pharmacy Inc.
• 31.7. Wells Pharmacy Network
• 31.8. ZRT Laboratory LLC
• 31.9. BionPharma Inc.
• 31.10. Orion Pharma AB
• 31.11. Actiza Pharmaceutical Private Limited
• 31.12. Biostation
• 31.13. Advantage Pharmaceuticals Inc.
• 31.14. Bravado Labs
• 31.15. Neuva Aesthetics

32. Global Bioidentical Hormones Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bioidentical Hormones Market

34. Recent Developments In The Bioidentical Hormones Market

35. Bioidentical Hormones Market High Potential Countries, Segments and Strategies

• 35.1 Bioidentical Hormones Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bioidentical Hormones Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bioidentical Hormones Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료